Literature DB >> 2910829

Incidence of male breast cancer in Scandinavia, 1943-1982.

M Ewertz1, L Holmberg, S Karjalainen, S Tretli, H O Adami.   

Abstract

Male breast cancer incidence was examined in a collaborative study of data from the cancer registries in Denmark, Finland, Norway and Sweden, comprising a total of 1,529 cases diagnosed from 1943 to 1982. Effects of age, time of diagnosis, birth cohort and country of residence were evaluated by using statistical models of the multiplicative Poisson type. The logarithm of incidence increased linearly with the logarithm of age and had a slope of about 5. In Denmark, male breast cancer incidence increased significantly with time, about 1% per year. No significant time effects were observed in the other countries. A significant effect of birth cohort appeared in Sweden only, but there was no particular trend in incidence by year of birth. In relation to Denmark, the risk of male breast cancer was lower in Sweden, Norway and Finland, the relative risk estimates with 95% confidence intervals being 0.82(0.72-0.94), 0.72(0.61-0.84) and 0.53(0.43-0.64) respectively. The variation within Scandinavia is similar for female breast cancer, pointing to common factors being involved in the etiology of breast cancer in both sexes.

Entities:  

Mesh:

Year:  1989        PMID: 2910829     DOI: 10.1002/ijc.2910430107

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

1.  Male breast cancer: a population-based comparison with female breast cancer.

Authors:  William F Anderson; Ismail Jatoi; Julia Tse; Philip S Rosenberg
Journal:  J Clin Oncol       Date:  2009-12-07       Impact factor: 44.544

2.  The Management and Outcomes of Male Breast Cancer.

Authors:  Ömer Uslukaya; Metehan Gümüş; Hatice Gümüş; Zübeyir Bozdağ; Ahmet Türkoğlu
Journal:  J Breast Health       Date:  2016-10-01

Review 3.  Breast cancer and cytomegalovirus.

Authors:  A K Richardson; L C Walker; B Cox; H Rollag; B A Robinson; H Morrin; J F Pearson; J D Potter; M Paterson; H-M Surcel; E Pukkala; M J Currie
Journal:  Clin Transl Oncol       Date:  2019-06-29       Impact factor: 3.405

4.  Expression of prostate specific antigen in male breast cancer.

Authors:  P J Carder; V Speirs; J Ramsdale; M R J Lansdown
Journal:  J Clin Pathol       Date:  2005-01       Impact factor: 3.411

Review 5.  Male breast cancer: an update in diagnosis, treatment and molecular profiling.

Authors:  Susan Onami; Melanie Ozaki; Joanne E Mortimer; Sumanta Kumar Pal
Journal:  Maturitas       Date:  2010-02-06       Impact factor: 4.342

Review 6.  Male reproductive health and environmental xenoestrogens.

Authors:  J Toppari; J C Larsen; P Christiansen; A Giwercman; P Grandjean; L J Guillette; B Jégou; T K Jensen; P Jouannet; N Keiding; H Leffers; J A McLachlan; O Meyer; J Müller; E Rajpert-De Meyts; T Scheike; R Sharpe; J Sumpter; N E Skakkebaek
Journal:  Environ Health Perspect       Date:  1996-08       Impact factor: 9.031

7.  Racial differences in cancer of the male breast--15 year experience in the Detroit metropolitan area.

Authors:  M S Simon; E McKnight; A Schwartz; S Martino; G M Swanson
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

8.  Rare case of male breast cancer and axillary lymphoma in the same patient: an unique case report.

Authors:  Emiliano Sordi; Katia Cagossi; Maria Grazia Lazzaretti; Daniel Gusolfino; Fabrizio Artioli; Giovanni Santacroce; Maria Luisa Brandi; Prisco Piscitelli
Journal:  Case Rep Med       Date:  2011-10-11

9.  A Clinicopathological Evaluation of Male Patients with Breast Cancer.

Authors:  Enver Ilhan; Bakir Bati; Ali Alemdar; Ali Coskun; Arsenal Sezgin; Mehmet Yildirim; Omer Engin; Mete Purten
Journal:  Breast Care (Basel)       Date:  2009-10-01       Impact factor: 2.860

10.  Breast cancer: trends in international incidence in men and women.

Authors:  E Kreiter; A Richardson; J Potter; Y Yasui
Journal:  Br J Cancer       Date:  2014-02-11       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.